Depending on the type of peptide used, therapy may help: At our clinic, peptide therapy is always part of a personalized plan designed to support your specific needs
For instance, in a pilot phase-I clinical study by Dorr et al., three subjects were subcutaneously administered a starting dose of 0.01 mg/kg of MT-II, followed by daily injections of MT-II or placebo for two consecutive weeks
Veja o infogrfico que preparamos para voc com o resumo do que falamos aqui neste artigo:
Cho S, Lee YH, Park H et al (2001) Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1
A maximum of 3-4 injections per year can be given, which can easily lead to dependence
And for patients who do eventually have surgery, GLP-1s are increasingly part of the picture before and after